Nasdaq: LXRX
Lexicon Pharmaceuticals insiders
The officers, directors and 10% owners of Lexicon Pharmaceuticals, Inc. who hold the most stock, valued at the live LXRX price.
$1.67
LXRX today −$50K (−2.91%)
Market closed. Prices as of Nov 19, 4:04 PM ET
- Ranked insiders
- 3
- Their LXRX stock
- $532M
- Market value
- $744M
- Held by ranked insiders
- 71.6%
Insiders by value of LXRX holdings
SEC ownership page| # | Insider | Role | Shares | Value | Of company | Overall rank |
|---|---|---|---|---|---|---|
| 1 | Artal International Management S.A. | Director | 175,156,062 | $293M | 39.3% | Corporate |
| 2 | Artal Participations S.a r.l. | Director | 136,180,481 | $227M | 30.6% | Corporate |
| 3 | Raymond Debbane | Director | 7,446,702 | $12.4M | 1.67% | 7000th |
Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for Lexicon Pharmaceuticals; see each profile for the filing.